Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4641806
Max Phase: Preclinical
Molecular Formula: C37H47Br2N9O5
Molecular Weight: 857.65
Molecule Type: Unknown
Associated Items:
ID: ALA4641806
Max Phase: Preclinical
Molecular Formula: C37H47Br2N9O5
Molecular Weight: 857.65
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N(C(N)=O)c2ccccc2)CC1)C(=O)N1CCN(c2ccncc2)CC1
Standard InChI: InChI=1S/C37H47Br2N9O5/c38-29-22-25(23-30(39)33(29)49)24-32(44-37(53)47-16-11-28(12-17-47)48(36(41)52)27-6-2-1-3-7-27)34(50)43-31(8-4-5-13-40)35(51)46-20-18-45(19-21-46)26-9-14-42-15-10-26/h1-3,6-7,9-10,14-15,22-23,28,31-32,49H,4-5,8,11-13,16-21,24,40H2,(H2,41,52)(H,43,50)(H,44,53)/t31-,32+/m0/s1
Standard InChI Key: TYOGCTPXYBIGHG-AJQTZOPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 857.65 | Molecular Weight (Monoisotopic): 855.2067 | AlogP: 3.95 | #Rotatable Bonds: 13 |
Polar Surface Area: 190.46 | Molecular Species: BASE | HBA: 8 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 6.75 | CX Basic pKa: 10.20 | CX LogP: 1.29 | CX LogD: 0.54 |
Aromatic Rings: 3 | Heavy Atoms: 53 | QED Weighted: 0.16 | Np Likeness Score: -0.78 |
1. Dubowchik GM, Conway CM, Xin AW.. (2020) Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success., 63 (13): [PMID:32058712] [10.1021/acs.jmedchem.9b01810] |
Source(1):